30-day mortality for femoral fragility fractures during COVID-19 [COVID-19]

  • Research type

    Research Study

  • Full title

    The effect of the COVID-19 pandemic on the treatment and outcomes of patients with femoral fragility fractures

  • IRAS ID

    283952

  • Contact name

    Paul Hamilton

  • Contact email

    paul.hamilton1@nhs.net

  • Sponsor organisation

    Epsom and St Helier NHS Trust

  • Duration of Study in the UK

    0 years, 0 months, 28 days

  • Research summary

    This is a single centre, retrospective, cohort study based at St Helier Hospital in Carshalton, South West London. This study aims to evaluate the impact of the COVID-19 pandemic on NOF management, length of stay and 30-day mortality in both COVID-19 positive and negative patients in a high-volume hip fracture unit in a district general hospital.

  • REC name

    N/A

  • REC reference

    N/A